Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Munoz

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Nature Medicine|April 17, 2025
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cellsFabian Müller, Andreas Wirsching, Melanie Hagen, et al.
Journal of Leukocyte Biology|July 31, 2025
Loss of myeloperoxidase aggravates skin and joint inflammation in the mannan-induced psoriatic arthritis mouse modelMark Ringer, Antonio Maccataio, Rico Zapf, et al.
Nature Medicine|September 15, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosusAndreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, et al.
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Nature Immunology|November 19, 2021
Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote T<sub>H</sub>2 and inhibit T<sub>H</sub>17 cell polarizationJohannes U Mayer, Kerry L Hilligan, Jodie S Chandler, et al.
Plos Neglected Tropical Diseases|September 14, 2017
Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015Kay M Tomashek, Olga D Lorenzi, Doris A Andújar-Pérez, et al.
Cell Reports|May 14, 2022
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Nature Medicine|April 17, 2025
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cellsFabian Müller, Andreas Wirsching, Melanie Hagen, et al.
Journal of Leukocyte Biology|July 31, 2025
Loss of myeloperoxidase aggravates skin and joint inflammation in the mannan-induced psoriatic arthritis mouse modelMark Ringer, Antonio Maccataio, Rico Zapf, et al.
Nature Medicine|September 15, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosusAndreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, et al.
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Nature Immunology|November 19, 2021
Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote T<sub>H</sub>2 and inhibit T<sub>H</sub>17 cell polarizationJohannes U Mayer, Kerry L Hilligan, Jodie S Chandler, et al.
Plos Neglected Tropical Diseases|September 14, 2017
Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015Kay M Tomashek, Olga D Lorenzi, Doris A Andújar-Pérez, et al.
Cell Reports|May 14, 2022
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Pageof 5